---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-003118"
form_type: "8-K"
ticker: "ENTA"
cik: "0001177648"
company_name: "ENANTA PHARMACEUTICALS INC"
filed_at: "2022-03-08T23:59:59+00:00"
generated_at: "2026-06-27T00:39:16.178688+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Enanta stockholders approve all proposals at 2022 annual meeting

## Summary
- Elected Mark Foletta (16,269,503 votes for) and Lesley Russell (16,081,968 votes for) as Class III directors.
- Approved amendment to 2019 Equity Incentive Plan, increasing reserved shares by 1,050,000.
- Advisory say-on-pay proposal passed with 16,369,060 votes for, 933,286 against.
- Ratified PricewaterhouseCoopers LLP as independent auditor for fiscal 2022 with 18,378,176 votes for.

## SEC filing metadata
- accession: 0000950170-22-003118
- form_type: 8-K
- ticker: ENTA
- cik: 0001177648
- company_name: ENANTA PHARMACEUTICALS INC
- filed_at: 2022-03-08T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1177648/000095017022003118/0000950170-22-003118-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1177648/000095017022003118/enta-20220303.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-003118
- JSON: https://secwatch.observer/filing/0000950170-22-003118.json
- Plain text: https://secwatch.observer/filing/0000950170-22-003118.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.